When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LIFE - aTyr Pharma rises on U.S. patent for anti-neuropilin-2 monoclonal antibodies
aTyr Pharma Inc.
aTyr Pharma ( NASDAQ: LIFE ) said on Thursday the U.S. Patent and Trademark Office had issued a patent covering the company's methods for the use of anti-neuropilin-2 (NRP2) antibodies to treat cancer and inflammation.
The blocking antibodies that aTyr has developed target distinct domains of NRP2, including those interacting with semaphorins, VEGF and certain chemokines.